Significant variation of the elevated nitric oxide levels in aqueous humor from patients with different types of glaucoma

Ophthalmologica

Volumn 216, Issue 5, 2002, Pages 346-350

  Tsai, Der Chong ^a   Hsu, Wen Ming ^a   Chou, Ching Kuang ^a   Chen, Shih Jen ^a   Peng, Chi Hsien ^a   Chi, N Wen ^a   Ho, Larry L T ^a   Liu, Jorn Hon ^a   Chiou, Shih Hwa ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Aqueous humor; Chemiluminescence; Glaucoma; Nitric oxide; Plasma

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; APOPTOSIS; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLOSED ANGLE GLAUCOMA; CONCENTRATION (PARAMETERS); DIABETIC RETINOPATHY; DISEASE SEVERITY; EYE BLOOD FLOW; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; OPEN ANGLE GLAUCOMA; PATHOGENESIS; REGULATORY MECHANISM; RETINA GANGLION CELL; SYSTEMIC DISEASE; CATARACT; CHEMOLUMINESCENCE; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; OSMOLARITY;

AGED; AQUEOUS HUMOR; CATARACT; CHEMILUMINESCENT MEASUREMENTS; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, NEOVASCULAR; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OSMOLAR CONCENTRATION;

EID: 0036718303     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066187     Document Type: Article

References (22)

1. Maepea O, Bill A: The pressure in the episcleral veins. Schlemm's canal and the trabecular meshwork in monkeys: Effects of changes in intraocular pressure. Exp Eye Res 1989;49:645-663.
2. Leske MC: The epidemiology of open-angle glaucoma: A review. Am J Epidemiol 1983;118:166-191.
3. Alwerd WLM: Medical management of glaucoma. N Engl J Med 1998;339:1298-1307.
4. Lowenstein CJ, Snyder SH: Nitric oxide, a novel biological messenger. Cell 1992;70:705-707.
5. Wiederholt M, Sturm A, Lepple-Wienhues A: Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci 1994;35:2515-2520.
6. Flugel C, Barany EH, Lutjen-Drecol E: Histochemical differences within the ciliary muscle and its function in accommodation. Exp Eye Res 1990;50:219-226.
7. Schuman JS, Erickson-Lamy K, Nathanson JA: Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp Eye Res 1994;58:99-105.
8. Nathanson JA: Nitric oxide and nitrovasodilators in the eye: Implication for ocular physiology and glaucoma. J Glaucoma 1993;2:206-210.
9. Nathanson JA, McKee M: Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 1995;36:1774-1784.
10. Dielemans I, DeJong PT, Stock FR. Vingerling JR, Grobbee DE, Hofman A: Primary open-angle glaucoma, intraocular pressure, and diabetes mellitus in the general elderly population. Ophthalmology 1996;103:1271-1275.
11. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwanoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorder. N Engl J Med 1994;331:1480-1487.
12. Witrenbichler B, Asahara T, Murohara T, Silver M, Spyridopous I, Manger M, Principe N, Kcarney M, Hu JS, Isner JM: Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998;153:381-394.
13. Sone H, Okuda Y, Kawakami Y, Suzuki MHH, Kozawa T, Honmura S, Yamashita K: Vascular endothelial growth factor level in aqueous humor of diabetic patients with rubebotic glaucoma is markedly elevated. Diabetes Care 1996;19:1306-1307.
14. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with non-proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 1997;38:36-47.
15. Tezel G, Kass MA, Kolker AE, Becker B, Wax MB: Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma 1996;6:83-89.
16. Yamamura T: Techniques for measurement of nitric oxide in biological system: Principles and practices: Nippon Yakurigaku Zasshi-Folia Pharmacologica Japonica 1996;107:173-182.
17. Chiou SH, Chang CJ, Hsu WM, Kao CL, Liu JH, Chen WL, Tsai DC, Wu CC, Chou CK: Elevated nitric oxide level in aqueous humor of patients with acute angle-closure glaucoma. Ophthalmologica 2001;215:113-116.
18. Neufeld AH, Sawada A, Becker B: Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA 1999;96:9944-9948.
19. Wang ZY, Alm P, Hakanson R: The contribution of nitric oxide to endotoxin-induced ocular inflammation: Interaction with sensory nerve fibers. Br J Pharm 1996;118:1537-1543.
20. Neufeld AH: Nitric oxide: A potential mediator of retinal ganglion cell damage in glaucoma. Surv Ophthalmol 1999;43(suppl 1):S129-S135.
21. Chiou SH, Chang CJ, Chou CK, Hsu WM, Liu JH, Chiang CH: Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma. Diabetic Care 1999;22:861-862.
22. Aiello LP, Wong JS: Role of vascular endothelial growth factor in diabetic vascular complications. Kidney International 2000;77(suppl):S113-119.